¼¼°èÀÇ ¸Åµ¶ °Ë»ç ½ÃÀå : À¯Çüº°, °Ë»ç Àå¼Òº°, Áö¿ªº°(2025-2033³â)
Syphilis Testing Market by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and Region 2025-2033
»óǰÄÚµå : 1636351
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 138 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,130,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,507,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,884,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸Åµ¶ °Ë»ç ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 13¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ÀÌ ½ÃÀåÀÌ 2033³â±îÁö 20¾ï ´Þ·¯¿¡ µµ´ÞÇÏ¿© 2025-2033³â°£ 4.9%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ¼ºº´(STD)ÀÇ È®»ê, À¯»ê Áõ°¡, ÇコÄÉ¾î ºÐ¾ß¿¡¼­ È¿°úÀûÀÎ Áúº´ Áø´Ü ¹× °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù.

¸Åµ¶Àº ¼ºº´(STI)ÀÇ ÀÏÁ¾À¸·Î º¸Åë ¼º Á¢ÃË¿¡ ÀÇÇØ ¹ß»ýÇϸç, ÇÇºÎ¿Í Á¡¸· Á¢ÃËÀ» ÅëÇØ °³ÀÎ °£¿¡ Àü¿°µË´Ï´Ù. »ý½Ä±â³ª ±¸°­ Á÷Àå¿¡ ÅëÁõÀÌ ¾ø´Â ¼öÆ÷°¡ »ý±â¸é¼­ ½ÃÀ۵˴ϴÙ. Ä¡·áÇÏÁö ¾Ê°í ¹æÄ¡ÇÏ¸é ³ú, ½Å°æ, Ç÷°ü, °üÀýÀ» ¼Õ»ó½ÃŰ´Â 3Â÷ ¸Åµ¶ÀÇ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇöÀç ½Å¼Ó Ç÷Àå ¹ÝÀÀ °Ë»ç(RPR)¿Í ¼ºº´ °Ë»ç(VDRL)°¡ Ç¥ÁØ °Ë»ç¹ýÀ¸·Î °³¾÷ÀǵéÀÌ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº ´õ ³ªÀº Ä¡·á¸¦ À§ÇÑ Á¶±â ¹ß°ßÀ» Á¦°øÇÏ°í ¼ºº´(STD)ÀÇ È®»ê°ú ¹ßº´À» ¿ÏÈ­ÇÕ´Ï´Ù. °á°úÀûÀ¸·Î ¸Åµ¶ °Ë»ç´Â ¸Åµ¶ À¯ÇüÀ» Áø´ÜÇϰí ÀûÀýÇÑ Ä¡·á¸¦ ½Äº°Çϱâ À§ÇØ ½ÇÇè½Ç°ú ÇöÀå Áø·á(PoC) ¼¾ÅÍ¿¡¼­ ¸Åµ¶ °Ë»ç¸¦ ÀÚÁÖ »ç¿ëÇÕ´Ï´Ù.

¸Åµ¶ °Ë»ç ½ÃÀå µ¿Çâ :

¼ºº´ Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö´Â °ÍÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ¿¡ µû¶ó ¿©·¯ ±¹°¡ÀÇ Á¤ºÎ, ºñÁ¤ºÎ±â±¸(NGO)°¡ ¸Åµ¶À» Æ÷ÇÔÇÑ ¼ºº´ ¿¹¹æ ¹× Ä¡·á¹ý¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀ» ³ôÀ̱â À§ÇÑ Ä·ÆäÀÎÀ» Ȱ¹ßÈ÷ ÁøÇàÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú ¸Åµ¶ ½Å¼Ó °Ë»ç ŰƮ¿Í °°Àº ¸Åµ¶ °Ë»ç ŰƮÀÇ º¸±ÞÀÌ ÃËÁøµÇ¾î ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Å°Æ®´Â È¿°úÀûÀÎ Áø´Ü °á°ú¿Í ÇÔ²² °¡Á¤ ³» °Ë»ç¸¦ Á¦°øÇÏ¿© Àû½Ã¿¡ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ¾î ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ °Ë»ç ŰƮ´Â ¿Â¶óÀÎ ¼Ò¸ÅÁ¡À̳ª ¸ÅÀå ³» ¾à±¹¿¡¼­ Àú·ÅÇÑ °¡°ÝÀ¸·Î ±¸ÀÔÇÒ ¼ö ÀÖ¾î »ç¿ë ÆíÀǼºÀÌ ³ô¾Æ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, ÀÇ·á ºÎ¹®ÀÇ »ó´çÇÑ °³¼±°ú È¿°úÀûÀÎ Ä¡·á ´ë¾ÈÀ» Ãâ½ÃÇϱâ À§ÇÑ ÃÖ±ÙÀÇ ¿¬±¸ °³¹ß(R&D) Ȱµ¿Àº ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ºº´ °Ë»ç¿¡ ´ëÇÑ À¯¸®ÇÑ ÀÇ·áºñ ȯ±Þ Á¤Ã¥ÀÌ Á¸ÀçÇÑ´Ù´Â Á¡µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¸Åµ¶À» Æ÷ÇÔÇÑ ¼ºº´ÀÇ À¯º´·ü Áõ°¡, ¹«¹æºñ ¼º°ü°è Áõ°¡, È¿°úÀûÀÎ °ËÁø ÇÁ·Î±×·¥ÀÇ ±¤¹üÀ§ÇÑ ½ÃÇà, Áúº´ÀÇ Á¶±â Áø´Ü¿¡ ´ëÇÑ ÁýÁßÀûÀÎ ³ë·Â °­È­¿Í °°Àº ´Ù¸¥ ¿äÀε鵵 ½ÃÀå Àü¸ÁÀ» ¹à°Ô ¸¸µé°í ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ ¸Åµ¶ °Ë»ç ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦7Àå ½ÃÀå ºÐ¼® : °Ë»çÀå¼Òº°

Á¦8Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀΰú ±âȸ

Á¦10Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦11Àå PorterÀÇ Five Forces ºÐ¼®

Á¦12Àå °¡°Ý ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global syphilis testing market size reached USD 1.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The growing prevalence of sexually transmitted diseases (STDs), the increasing incidences of miscarriages, and the rising need for effective disease diagnosing and testing solutions in the healthcare sector represent some of the key factors driving the market.

Syphilis refers to a sexually transmitted infection (STI) that is usually caused by sexual contact and is spread amongst individuals through the skin or mucous membrane contact. It starts as a painless sore on the genitals and rectum of the mouth. If left untreated, it might trigger complications of tertiary syphilis, wherein the disease may damage the brain, nerves, blood vessels, and joints. At present, rapid plasma reagin (RPR) and venereal diseases research laboratory (VDRL) are standard testing practices that are being used by practitioners. These approaches provide early detection for better treatment and mitigate the spread and development of sexually transmitted diseases (STDs). As a result, syphilis testing is frequently used in laboratories and point-of-care (PoC) centers to diagnose the syphilis type and identify its proper treatment.

Syphilis Testing Market Trends:

The increasing awareness regarding STD treatment represents one of the key factors driving the market growth. In line with this, governments of various nations, along with different non-governmental organizations (NGOs) are actively undertaking campaigns to sensitize the common mass regarding the prevention of STDs, including syphilis, and the available treatment options. This, in turn, is facilitating the adoption of syphilis testing kits, such as syphilis rapid test strips, which is favorably supporting the market growth. These kits offer at-home testing with effective diagnostic results, and thus timely decision-making, which is also contributing to the market growth. Additionally, the convenience of usage and the easy availability of these test kits at online retail stores and in-store pharmacies at affordable price points are contributing to the market growth. Apart from this, the considerable improvements in the healthcare sector and the recent research and development (R&D) activities to launch effective treatment alternatives are positively impacting the market growth. Moreover, the presence of favorable medical reimbursement policies for the testing of sexually transmitted infections is contributing to the market growth. Other factors, such as the increasing prevalence of STDs, including syphilis, rising incidences of unprotected sexual intercourse, the widespread implementation of effective screening programs, and an enhanced focus on the early diagnostic of the disease, are creating a positive outlook for the market.

Key Market Segmentation:

Type Insights:

Location of Testing Insights:

Regional Insights:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Syphilis Testing Market

6 Market Breakup by Type

7 Market Breakup by Location of Testing

8 Market Breakup by Region

9 Drivers, Restraints, and Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

12 Price Analysis

13 Competitive Landscape

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â